👀 Copy Legendary Investors' Portfolios in One ClickCopy For Free

UPDATE 2-European stocks end week with gains on telecoms, tech boost

Published 08/07/2020, 04:33 PM
Updated 08/08/2020, 12:10 AM
© Reuters.
DTEGn
-
GILD
-
HIK
-
RR
-
TMUS
-
STOXX
-
0700
-
SXEP
-
SXKP
-
SX7P
-
SXAP
-
PRX
-

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)
* Tech investor Prosus hit by U.S. move on Chinese apps
* Deutsche Telekom boosted by T-Mobile's upbeat Q2 report
* Main regional indexes record weekly gains

(Updates with market close)
By Sruthi Shankar
Aug 7 (Reuters) - European shares closed higher on Friday,
marking weekly gains as investors focused on a broadly
supportive earnings season and improving economic data in
Europe rather than rising U.S.-China tensions.
The main indexes spent the morning in the red after U.S.
President Donald Trump moved to ban U.S. transactions with the
Chinese owners of messaging app WeChat and video-sharing app
TikTok, further escalating friction with Beijing. Amsterdam-listed Prosus PRX.AS , with its biggest
investment in Tencent 0700.HK , fell 4.0%.
Markets, however, stabilised later, boosted by telecoms
.SXKP , technology .SX8P and healthcare .SXDP stocks.
The pan-European STOXX 600 index .STOXX , up 0.3%, closed
out with weekly gains of 2%. German stocks .GDAXI rose 0.7%,
while London's FTSE 100 .FTSE and France's CAC 40 .FCHI were
flat, but all logged weekly rises.
Data showed U.S. jobs increased by a better-than-expected
1.763 million in July, although the pace of recovery slowed amid
a resurgence in new coronavirus infections, pressuring the White
House and Congress to agree another aid package. "The jobs numbers were surprisingly good," said Nancy
Tengler, chief investment officer of Laffer Tengler Investments.
"But we expect a moderation in jobs improvement in the near-term
as businesses wait to see what Washington comes up with."
With the bulk of the European earnings season over,
investors were relieved that most companies had exceeded
analysts' much-lowered forecasts for quarterly profits.
Refinitiv data showed about 60% of the STOXX companies that have
reported so far beat estimates.
Hikma Pharmaceuticals HIK.L jumped 10.9% after saying it
had started manufacturing remdesivir, an approved treatment for
COVID-19 from U.S.-based Gilead GILD.O , and it raised its
annual sales outlook for two of its biggest divisions.
Deutsche Telekom DTEGn.DE , which owns 43% of T-Mobile
TMUS.O , rose 2.7% after the U.S. firm added more monthly
subscribers than expected in the second quarter and said it
surpassed rival AT&T T.N . The broader telecoms index .SXKP rose 1% to lead sectoral
gains, although stocks considered more sensitive to business
cycles, including banks SX7P , miners .SXPP and oil and gas
companies .SXEP , handed back some of this week's steady gains.
Standard Life Aberdeen's SLA.L shares inched higher after
the asset manager said it would pay a dividend even as its
profit dropped 30%.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.